RNA homologous to that of the Rauscher leukemia virus has been detected in Burkitt's lymphomas and nasopharyngeal carcinomas. Earlier excellent experimental evidence has linked these two human tumors with the Epstein-Barr virus, a DNA-containing agent.
The detection of viral-specific RNA in tumors (1) by molecular hybridization (2) has revealed that certain human neoplasias exhibit a specific pattern of viral-related RNAs remarkably similar to that observed in the corresponding viral-induced tumors of mice. Thus, human breast carcinomas contain an RNA possessing homology to that of the mouse mammary tumor virus. The breast tumor RNA exhibited no sequence relatedness to RNA of the Rauscher leukemia virus, an agent possessing no homology to mouse mammary tumor virus (manuscript in preparation). On the other hand, RNAs from human leukemic cells (3) , human sarcomas (4), Hodgkins' disease, and other human lymphomas (5) were all unrelated to that of the breast tumor virus, showing instead unique homology to the RNA of the leukemogenic Rauscher virus.
The pattern of specificities exhibited by the human tumors examined are in accord with the experience accumulated with the mouse experimental system. It was of obvious interest to subject this intriguing parallelism to further scrutiny by a similar analysis of Burkitt's lymphoma and nasopharyngeal carcinoma, both of which have been experimentally related to the DNA-containing Epstein-Barr virus.
Burkitt's disease, a malignant lymphoma, is the most common cancer found in children living in a geographical belt extending across Central Africa. Epidemiological (6, 7) , serological (7, 8) , and nucleic acid hybridization (9) studies have linked this disease to the herpes-like Epstein-Barr virus detected in (10) and isolated (11) from Burkitt's lymphoma cells grown in culture. Nasopharyngeal carcinoma, a tumor containing both epithelial and lymphoid elements (12) , is prevalent in certain groups in the Far East. Serological (8, 13) and hybridization (9) evidence has similarly implicated the Epstein-Barr virus in this disease.
Though arresting, such correlative data cannot by themselves permit a definitive decision on whether Epstein-Barr virus is causative or contributory in these diseases (14) . Even finding sequences from this virus in the relevant human cancer cells is not conclusive, and particularly so until other types of "oncogenic" information have been sought for and eliminated as possible participants in the carcinogenic process. To shed light on these and related issues, we address ourselves to the following question: Do Burkitt's lymphomas 5 and nasopharyngeal carcinomas contain RNA homologous to that of the RNA tumor viruses found in our studies (1) (2) (3) (4) (5) In studies such as those contemplated here, it must be shown before use that the radioactive DNA product bands solely in the DNA density region of a Cs2504 gradient and that it hybridizes with homologous RNA, and not to normal cellular RNA.
The RNA (designated as polysomal RNA) used in the hybridizations is derived from a cytoplasmic pellet consisting of a mixture of monosomes and polysomes. Suitable care must be exercised to insure the complete removal of protein contaminants. Proc. Nat. Acad. SCi. USA 70 (1973) lymphoma polysomal RNA ( Fig. 2A) DNA has been hybridized.
As in previous studies, a method of recording our findings has been adopted that avoids the inconvenience of presenting the Cs2SO4 gradient of every tissue examined. After correction for background counts, the sum of the tritium counts in the RNA density region (density 1.62-1.69 g/ml) was used to measure the amount of DNA complexed to RNA. To achieve the accuracy desired, 10-min counts (cplOm) were taken on each sample. An operational mean background and its standard deviation (S) were empirically determined for individual machines from the total cplOm of three tubes in the negative region (i.e., tubes 2, 3, and 4) of each of 60 gradients. The convention was adopted that specimens showing a cplOm of less than three standard deviations of the background mean were considered negative. Tables 1 and 2 [3H] DNA, and the reactions were subjected to CS9604 equilibrium centrifugation. The data are expressed on cpl0m (corrected for background) banding in the RNA region of the gradient, and as multiples of the standard deviation (S) (as described in the legends to Table 1 the relevant RNA, whether the tissue being tested is neoplastic or normal. In the first place, all of the samples tested in the present series were collected in laboratories remote from our own. Any significant delay between removal and freezing of the sample, or if it suffers more than one freezing and thawing, can lead to loss of the relevant RNA by nucleolytic degradation. The sensitivity of detection of complementary RNA is limited by the amount of polysomal RNA that can be dissolved in the annealing mixture, a difficulty that will be obviated by the development of a suitable enrichment procedure for the pertinent RNA fraction. Finally, it may be of RNA homologous to that of Rauscher virus is obviously an observation worthy of note to those who wish to understand the biology of these tumors. The etiologic questions and implications generated by these findings will be resolved only by further investigation. There also remains the question of a possible homology between Epstein-Barr virus-DNA and
